NGD 94-4 small molecule dopamine D4 antagonist data

NRGN announced that interim results of its Phase I trial suggest that

Read the full 124 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE